Risk of fatal cerebrovascular accidents after external beam radiation therapy for early-stage glottic laryngeal cancer.
Swisher-McClure, Samuel MD 1; Mitra, Nandita PhD 3; Lin, Alexander MD 1,4; Ahn, Peter MD 1,4; Wan, Fei MS 3; O'Malley, Bert MD 2; Weinstein, Gregory S. MD 2; Bekelman, Justin E. MD 1,3,4,5
[Article] Head & Neck. 36(5):611-616, May 2014.

(Format: HTML, PDF)

Background. This study compared the risk of fatal cerebrovascular accidents (CVAs) in patients with early-stage glottic laryngeal cancer receiving surgery or external beam radiation therapy (EBRT).

Methods. Using a competing risks survival analysis, we compared the risk of death because of CVA among patients with early-stage glottic laryngeal cancer receiving surgery or EBRT in the Surveillance, Epidemiology, and End Results (SEER) database.

Results. The cumulative incidence of fatal CVA at 15 years was higher in patients receiving EBRT (2.8%; 95% confidence interval [CI], 2.3% to 3.4%) compared to surgery (1.5%; 95% CI, 0.8% to 2.3%; p = .024). In multivariable competing risks regression models, EBRT remained associated with an increased risk of fatal CVA compared to surgery (adjusted hazard ratio [HR], 1.75; 95% CI, 1.04-2.96; p = .037).

Conclusion. Treatment for early-stage glottic laryngeal cancer with EBRT was associated with a small increase in the risk of late fatal CVA events relative to surgery.

(C) 2014 John Wiley & Sons, Ltd